State of Michigan Retirement System boosted its holdings in shares of Agilent Technologies Inc (NYSE:A) by 11.2% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 78,906 shares of the medical research company’s stock after purchasing an additional 7,937 shares during the period. State of Michigan Retirement System’s holdings in Agilent Technologies were worth $6,973,000 at the end of the most recent quarter.
A number of other large investors have also modified their holdings of the stock. NuWave Investment Management LLC raised its holdings in Agilent Technologies by 1,116.1% during the 1st quarter. NuWave Investment Management LLC now owns 377 shares of the medical research company’s stock worth $27,000 after buying an additional 346 shares during the period. Ameritas Investment Company LLC increased its position in shares of Agilent Technologies by 169.1% in the first quarter. Ameritas Investment Company LLC now owns 444 shares of the medical research company’s stock worth $31,000 after acquiring an additional 279 shares in the last quarter. Sowa Financial Group Inc. raised its holdings in shares of Agilent Technologies by 1,425.0% during the first quarter. Sowa Financial Group Inc. now owns 488 shares of the medical research company’s stock valued at $35,000 after acquiring an additional 456 shares during the period. Patriot Financial Group Insurance Agency LLC lifted its position in shares of Agilent Technologies by 1,570.8% in the 2nd quarter. Patriot Financial Group Insurance Agency LLC now owns 401 shares of the medical research company’s stock valued at $35,000 after acquiring an additional 377 shares in the last quarter. Finally, Sterling Investment Advisors Ltd. acquired a new position in Agilent Technologies in the 2nd quarter worth approximately $35,000.
Shares of NYSE:A opened at $96.33 on Friday. The company has a current ratio of 1.63, a quick ratio of 1.24 and a debt-to-equity ratio of 0.38. The stock has a market capitalization of $29.74 billion, a PE ratio of 44.39, a P/E/G ratio of 3.09 and a beta of 1.12. Agilent Technologies Inc has a 1 year low of $61.13 and a 1 year high of $98.09. The firm has a fifty day moving average price of $90.28 and a 200 day moving average price of $82.78.
Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Thursday, May 21st. The medical research company reported $0.71 EPS for the quarter, beating the Zacks’ consensus estimate of $0.61 by $0.10. The business had revenue of $1.24 billion for the quarter, compared to analyst estimates of $1.20 billion. Agilent Technologies had a return on equity of 20.76% and a net margin of 13.04%. The firm’s revenue for the quarter was up .2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.71 EPS. On average, sell-side analysts forecast that Agilent Technologies Inc will post 3.12 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th were issued a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 0.75%. The ex-dividend date of this dividend was Monday, June 29th. Agilent Technologies’s dividend payout ratio is currently 23.15%.
In other Agilent Technologies news, Director Heidi Fields sold 10,392 shares of Agilent Technologies stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $91.00, for a total value of $945,672.00. Following the transaction, the director now directly owns 53,509 shares of the company’s stock, valued at approximately $4,869,319. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, VP Rodney Gonsalves sold 4,566 shares of the company’s stock in a transaction that occurred on Wednesday, May 27th. The stock was sold at an average price of $85.30, for a total value of $389,479.80. Following the transaction, the vice president now owns 102,806 shares of the company’s stock, valued at $8,769,351.80. The disclosure for this sale can be found here. Insiders sold a total of 42,009 shares of company stock worth $3,558,488 over the last quarter.
A number of analysts have recently issued reports on the company. Zacks Investment Research lowered Agilent Technologies from a “buy” rating to a “hold” rating and set a $89.00 target price for the company. in a report on Friday, June 12th. Goldman Sachs Group started coverage on Agilent Technologies in a research note on Monday, July 13th. They issued a “neutral” rating for the company. Royal Bank of Canada began coverage on Agilent Technologies in a research report on Tuesday, April 28th. They set a “sector perform” rating for the company. Wells Fargo & Co upped their target price on Agilent Technologies from $82.00 to $95.00 and gave the company an “overweight” rating in a report on Friday, May 22nd. Finally, Cfra decreased their price target on shares of Agilent Technologies from $89.00 to $85.00 and set a “hold” rating for the company in a report on Friday, May 22nd. Thirteen investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $83.17.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.
Recommended Story: Why is the price target of stocks important?
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.